Literature DB >> 19594420

Factors modulating fibrates response: therapeutic implications and alternative strategies.

M I Panadero1, M C González, E Herrera, C Bocos.   

Abstract

Peroxisome proliferator-activated receptor alpha (PPARalpha) regulates transcription of genes involved both in lipid and glucose metabolism as well as in inflammation. Fibrates are PPARalpha ligands used to normalize lipid and glucose parameters and exert antiinflammatory effects. In fact, fibrates have already been demonstrated to benefit metabolic syndrome, type 2 diabetes and cardiovascular diseases. This article reviews the mechanism of action and the functional roles of fibrates, emphasizing the factors modulating their capacity to activate PPARalpha and affecting their effectiveness. These factors may possibly explain the findings obtained in animal studies and clinical trials with fibrates which showed either untoward effects and/or inefficient hypolipidemic action of PPARalpha activation. We also discuss briefly the natural and synthetic agonists of PPARalphawhich are currently being developed and supposedly display greater effectiveness and fewer adverse effects than fibrates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19594420     DOI: 10.2174/187153009789044356

Source DB:  PubMed          Journal:  Endocr Metab Immune Disord Drug Targets        ISSN: 1871-5303            Impact factor:   2.895


  3 in total

1.  Fish oil diet in pregnancy and lactation reduces pup weight and modifies newborn hepatic metabolic adaptations in rats.

Authors:  Maria J Jiménez; Carlos Bocos; Maribel Panadero; Emilio Herrera
Journal:  Eur J Nutr       Date:  2015-11-14       Impact factor: 5.614

2.  Peroxisome proliferator-activated receptorα agonists differentially regulate inhibitor of DNA binding expression in rodents and human cells.

Authors:  María Del Carmen González; J Christopher Corton; Nuria Acero; Dolores Muñoz-Mingarro; Yolanda Quirós; Juan José Alvarez-Millán; Emilio Herrera; Carlos Bocos
Journal:  PPAR Res       Date:  2012-06-04       Impact factor: 4.964

3.  Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect.

Authors:  Fang Yan; Qi Wang; Chao Xu; Mingfeng Cao; Xiaoming Zhou; Tingting Wang; Chunxiao Yu; Fei Jing; Wenbin Chen; Ling Gao; Jiajun Zhao
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.